Analysis of efficacy and immunomodulatory activity of lenalidomide alone in relapse and refractory multiple myeloma
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 13 Feb 2017 Status changed from recruiting to completed.
- 09 Feb 2013 New trial record